Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma

NCT00005580 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT00005580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
September 30, 1998
Completion date
August 31, 2006
Enrollment
54 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma